Yiheng Capital Management, L.P.
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1447228
SAN FRANCISCO, CA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,082,856
-$2,412,977 QoQ
Shares Held
208,735
0.0% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Yiheng Capital Management, L.P. holds $14,933,232 across 5 Biotechnology names. VRDN ranks #2 (27.3% of the industry book) .
All Filings in VRDN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,082,856 | 208,735 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,495,833 | 208,735 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,795,632 | 500,261 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,993,648 | 500,261 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,743,518 | 500,261 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $14,382,503 | 750,261 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $19,289,520 | 847,891 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,335,171 | 948,130 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,601,756 | 948,130 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,757,470 | 1,228,534 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,845,711 | 1,228,534 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,226,823 | 1,228,534 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,253,904 | 1,228,534 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $28,136,707 | 963,256 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,651,276 | 373,051 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||